The electrocardiographic changes generated by centrally applied arachidonic acid in rats

Year 2022, Volume: 6 Issue: 3, 105 - 109, 31.12.2022

Esra Kaşıkcı Murat Yalçın

https://doi.org/10.30704/http-www-jivs-net.1175674

Abstract

Arachidonic acid (AA) and its metabolites have multifunctional regulatory effects on the central nervous system. Our previous reports disclosed that centrally injected AA organized the cardiovascular system in normal or hypotensive conditions by regulating the central and peripheral mechanism. In the light of the knowledge of the potential cardiovascular effects of AA, the current study aimed to investigate the effects of intracerebroventricular (ICV) injected AA on the electrocardiography (ECG) of the anesthetized rats. The adult Sprague Dawley rats were anesthetized with ketamine and xylazine mixture (50 mg/kg and 20 mg/kg; i.m., respectively). Under the anesthesia, the guide cannula was inserted into the left lateral ventricle of the rats. The ECG traces obtained from the lead II were written by placing electrodes on the limbs of the rats. Centrally injected AA (150 μg; ICV) statistically significantly (p<0.05) caused to the lengthening of the ECG waves and intervals, resulting in a decrease in the heart rate of the rats without changing the ECG waveforms, the amplitude, and also the isoelectric line. The obtained results clearly show that centrally injection of AA caused the deceleration in the heart electrical activity. The deceleration in the electrical activity of the heart caused to show bradycardia in the rats by extending the duration of the ECG waves and intervals.

Keywords

Arachidonic acid, Electrocardiography, Intracerebroventricular, Heart rate.

References

• Altinbas, B., Topuz, B. B., Ilhan, T., Yilmaz, M. S., Erdost, H., Yalcin, M. (2014). Activation of the central histaminergic system mediates arachidonic-acid-induced cardiovascular effects. Canadian Journal of Physiology and Pharmacology, 92, 645-654.
• Aydin, C., Yalcin, M. (2008). Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid. Prostaglandins, Leukotrienes and Essential Fatty Acids, 78, 361–368.
• Bosetti, F. (2007). Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models. Journal of Neurochemistry, 102, 577-586.
• Erkan, L. G., Altinbas, B., Guvenc, G., Aydin, B., Niaz, N., Yalcin, M. (2017). The acute cardiorespiratory effects of centrally injected arachidonic acid; the mediation of prostaglandin E, D and F2α. Respiratory Physiology and Neurobiology, 242, 117-124.
• Erkan, L. G., Guvenc, G., Altinbas, B., Niaz, N., Yalcin, M. (2016). The effects of centrally injected arachidonic acid on respiratory system: Involvement of cyclooxygenase to thromboxane signaling pathway. Respiratory Physiology and Neurobiology, 225, 1-7.
• Guvenc-Bayram, G., Altinbas, B., Erkan, L. G., Yalcin, M. (2020). Modulation of arachidonic acid-evoked cardiorespiratory effects by the central lipoxygenase pathway. Respiratory Physiology and Neurobiology, 278, 103441.
• Hall, J. E. (2011). Cardiac Arrhythmias and their electrocardiographic interpretation. In: Hall JE, Guyton AC, Schmitt W, eds. Guyton and Hall Textbook of Medical Physiology. 12th ed. Saunders, London, 143-153.
• Kasikci, E., Yalcin, M. (2022). Effect of ıntravenously ınjected arachidonic acid on electrocardiography in rats. Journal of Research in Veterinary Medicine, 41, (in press).
• Katsuki, H., Okuda, S. (1995). Arachidonic acid as a neurotoxic and neurotrophic substance. Progress in Neurobiology, 46, 607-636.
• Paxinos, G., Watson, C. (2005). The Rat Brain in Stereotaxic Coordinates. 4th ed., Academic Press, New York.
• Pifferi, P., Laurent, B., Plourde, M. (2021). Lipid transport and metabolism at the blood-brain interface: Implications in health and disease. Frontiers in Physiology, 12, 645646.
• Rapoport, S. I. (2008). Arachidonic acid and the brain The Journal of Nutrition, 138, 2515-2520.
• Wagner, G. S., Macfarlane, P., Wellens, H., et al. (2009). AHA/ ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. Journal of the American College of Cardiology, 53, 1003-1011.
• Yalcin, M., Savci, V. (2007). Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms. Neuropeptides, 41, 465–475.
• Yalcin, M., Ak, F., Erturk, M. (2006). The role of the central thromboxane A2 in cardiovascular effects of a phospholipase A2 activator melittin administrated intracerebroventricularly in normotensive conscious rats. Neuropeptides, 40, 207–212.
• Yalcin, M., Aydin, C., Savci, V. (2009). Cardiovascular effect of peripheral injected melittin in normotensive conscious rats: mediation of the central cholinergic system. Prostaglandins, Leukotrienes and Essential Fatty Acids, 81, 341–347.
• Yalcin, M., Aydin, C. (2009). Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism. Clinical and Experimental Pharmacology and Physiology, 36: 447–453.
• Yalcin, M., Aydin, C. (2011). The role of the central arachidonic acid-thromboxane A2 cascade in cardiovascular regulation during hemorrhagic shock in rats. Prostaglandins, Leukotrienes and Essential Fatty Acids, 85, 61-66.
• Yalcin, M., Cavun, S., Yilmaz, M. S., Cengiz, F., Savci, V. (2005a). Involvement of brain thromboxane A2 in hypotension induced by haemorrhagein rats. Clinical and Experimental Pharmacology and Physiology, 32, 960–967.
• Yalcin, M., Cavun, S., Yilmaz, M. S., Savci, V. (2005b). The involvement of central cholinergic system in the pressor effect of intracerebroventricularly injected U-46619, a thromboxane A2 analog, in conscious normotensive rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 372, 31–40.
• Yalcin, M., Savci, V. (2007). Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms. Neuropeptides, 41, 465–475.
• Yalcin, M., Savci, V. (2004). Restoration of blood pressure by centrally injected U-46619, a thromboxane A2 analog, in haemorhaged hypotensive rats: Investigation of different brain areas. Pharmacology, 70, 177–187.
• Yalcin, M. (2011). Central mechanism underlying pressor and bradycardic effect of intracerebroventricularly injected arachidonic acid. Canadian Journal of Physiology and Pharmacology, 89, 127-133.
• Yalcin, M., Erturk, M. (2007). The involvement of the central cholinergic system in the pressor and bradycardic effects of centrally administrated melittin in normotensive conscious rats. Neuropeptides, 41, 103–110.
• Zhang, D. Y., Anderson, A. S. (2014). The sympathetic nervous system and heart failure. Cardiology Clinics, 32, 33–vii.